Clinical Trial Update: Evaluating the Use of Large-dose, Extended Interval Vancomycin Intravenous Administration for Skin and Soft Tissue Infections [NA]

View source ↗

Summary

A completed clinical trial evaluating high-dose, extended-interval intravenous vancomycin for skin and soft tissue infections, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin and Soft Tissue Infections

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: Fraser Health | Conditions: Skin and Soft Tissue Infections | NA | Status: COMPLETED | Results posted: 2011-07-08